Headlines about Cerner Corporation (NASDAQ:CERN) have been trending somewhat positive this week, Accern Sentiment Analysis reports. The research group identifies negative and positive news coverage by analyzing more than twenty million blog and news sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Cerner Corporation earned a coverage optimism score of 0.20 on Accern’s scale. Accern also assigned headlines about the company an impact score of 46.1165575715988 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the immediate future.

Here are some of the headlines that may have effected Accern’s analysis:

Shares of Cerner Corporation (NASDAQ CERN) opened at 71.48 on Friday. The company has a market cap of $23.70 billion, a price-to-earnings ratio of 36.12 and a beta of 0.95. Cerner Corporation has a 12 month low of $47.01 and a 12 month high of $72.27. The firm has a 50-day moving average of $65.76 and a 200 day moving average of $63.29.

Cerner Corporation (NASDAQ:CERN) last announced its quarterly earnings data on Thursday, July 27th. The company reported $0.56 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.57 by ($0.01). The firm had revenue of $1.29 billion for the quarter, compared to analysts’ expectations of $1.30 billion. Cerner Corporation had a net margin of 13.47% and a return on equity of 18.18%. The business’s revenue for the quarter was up 6.3% compared to the same quarter last year. During the same period last year, the company posted $0.58 earnings per share. On average, analysts expect that Cerner Corporation will post $2.50 earnings per share for the current year.

Cerner Corporation announced that its Board of Directors has initiated a share repurchase plan on Thursday, May 25th that authorizes the company to buyback $500.00 million in outstanding shares. This buyback authorization authorizes the company to reacquire up to 2.3% of its shares through open market purchases. Shares buyback plans are generally an indication that the company’s leadership believes its stock is undervalued.

A number of equities analysts recently weighed in on CERN shares. Cantor Fitzgerald reissued a “buy” rating and set a $77.00 target price (up previously from $68.00) on shares of Cerner Corporation in a research note on Monday, June 5th. BidaskClub raised shares of Cerner Corporation from a “buy” rating to a “strong-buy” rating in a research note on Tuesday, June 27th. Canaccord Genuity reissued a “buy” rating and set a $69.00 target price on shares of Cerner Corporation in a research note on Wednesday, September 6th. J P Morgan Chase & Co reissued an “overweight” rating and set a $72.00 target price (up previously from $65.00) on shares of Cerner Corporation in a research note on Tuesday, June 6th. Finally, Robert W. Baird reissued a “hold” rating and set a $67.00 target price on shares of Cerner Corporation in a research note on Thursday, August 31st. Fifteen equities research analysts have rated the stock with a hold rating and six have given a buy rating to the stock. The stock currently has an average rating of “Hold” and an average price target of $65.71.

WARNING: “Cerner Corporation (CERN) Given Coverage Optimism Rating of 0.20” was first reported by Daily Political and is the sole property of of Daily Political. If you are viewing this piece of content on another publication, it was illegally stolen and reposted in violation of United States & international trademark and copyright laws. The legal version of this piece of content can be viewed at https://www.dailypolitical.com/2017/09/15/cerner-corporation-cern-given-coverage-optimism-rating-of-0-20.html.

In related news, Chairman Clifford W. Illig sold 118,113 shares of the firm’s stock in a transaction that occurred on Friday, August 11th. The shares were sold at an average price of $62.03, for a total value of $7,326,549.39. Following the transaction, the chairman now owns 1,229,719 shares of the company’s stock, valued at $76,279,469.57. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, President Zane M. Burke sold 94,000 shares of the firm’s stock in a transaction that occurred on Tuesday, September 5th. The stock was sold at an average price of $67.47, for a total transaction of $6,342,180.00. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 371,583 shares of company stock worth $24,758,191. Insiders own 13.20% of the company’s stock.

About Cerner Corporation

Cerner Corporation (Cerner) is a supplier of healthcare information technology (HCIT). The Company offers a range of intelligent solutions and services that support the clinical, financial and operational needs of organizations of all sizes. The Company’s segments include Domestic and Global. The Domestic segment includes revenue contributions and expenditures associated with business activity in the United States.

Insider Buying and Selling by Quarter for Cerner Corporation (NASDAQ:CERN)

Receive News & Ratings for Cerner Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerner Corporation and related companies with MarketBeat.com's FREE daily email newsletter.